Article Information
PubMed
Print ISSN
Online ISSN
History
- Received October 9, 2009
- Accepted December 18, 2009
- Published online February 17, 2010.
Article Versions
- Earlier version (December 18, 2009 - 08:16).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2010 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Malin Darnell,
- Johan E. Karlsson,
- Albert Owen,
- Ismael J. Hidalgo,
- Jibin Li,
- Wei Zhang and
- Tommy B. Andersson
- Clinical Pharmacology and DMPK, AstraZeneca R&D, Mölndal, Sweden (M.D., J.E.K., T.B.A.); Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (M.D., T.B.A.); and Absorption Systems LP, Exton, Pennsylvania (A.O., I.J.H., J.L., W.Z.)
- Address correspondence to:
Dr. Tommy B. Andersson, Clinical Pharmacology and DMPK, AstraZeneca R&D Mölndal, S-431 83 Mölndal, Sweden. E-mail: tommy.b.andersson{at}astrazeneca.com
Parts of this work were previously presented at the following conference: Darnell M, Karlsson JE, Owen A, Hidalgo IJ, Li J, Zhang W, and Andersson TB (2008) Investigation of transporters involved in biliary clearance of drugs in the human liver using Caco-2 cells with stable MDR1 and MRP2 knockdown by shRNA. 2008 Society for Neuroscience; 2007 Oct 12–15; San Diego, CA. International Society for the Study of Xenobiotics, Washington, DC.